And by inhibiting the activation of the MET/PI3K/AKT pathway, the proliferation ability of diffuse large B-cell lymphoma cells was inhibited and their apoptosis was promoted. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.